Hold Drugmakers Accountable for California SJS Wrongful Deaths
TL;DR: SJS/TEN are rare but severe reactions sometimes associated with medications. In California, families may pursue a wrongful death claim and the estate may pursue a survival action. Viable theories often include failure-to-warn and manufacturing defect; strict-liability design-defect claims are generally unavailable for prescription drugs under California law. Deadlines can be short and vary by claim type—speak with counsel promptly. Contact us to discuss your options.
Understanding SJS/TEN and Drug Liability
Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare but severe conditions that can be triggered by certain medications and other factors and may be life-threatening. See background information from MedlinePlus. When a medication is credibly implicated, California law may allow a wrongful death action against responsible parties in the distribution chain.
Potential theories include strict products liability (e.g., failure to warn and manufacturing defect), negligence, and breach of warranty. However, California generally does not allow strict-liability design-defect claims against manufacturers of prescription drugs, even if the drug is unavoidably unsafe but properly prepared and accompanied by adequate warnings. See Brown v. Superior Court (1988) 44 Cal.3d 1049.
How California Wrongful Death and Survival Claims Work
California recognizes two related paths after a fatal injury:
- Wrongful death claims by eligible heirs for their own losses (e.g., loss of financial support, companionship). See Code Civ. Proc. § 377.60 and § 377.61.
- Survival actions by the decedent’s personal representative or successor in interest for harms the decedent sustained before death (e.g., economic losses and, within the statute’s effective period, certain non-economic damages). See § 377.30 and § 377.34.
California has allowed recovery of the decedent’s pre-death pain, suffering, or disfigurement in survival actions within the effective window set by § 377.34(b). An attorney can advise whether the timing of your case meets current statutory requirements.
Potential Theories Against Drug Manufacturers
- Failure to warn: allegations that labeling or communications to prescribers were inadequate or not timely updated as safety information emerged. See preemption context in Wyeth v. Levine, 555 U.S. 555 (2009) and Merck v. Albrecht, 587 U.S. ___ (2019).
- Manufacturing defect: the specific product deviated from specifications or quality standards.
- Negligence: inadequate testing, pharmacovigilance, or risk-minimization practices.
- Breach of warranty: express or implied warranty theories where applicable.
Important constraints include federal preemption—particularly for generic drugs (see PLIVA, Inc. v. Mensing, 564 U.S. 604 (2011) and Mutual Pharm. v. Bartlett, 570 U.S. 472 (2013))—and California’s learned-intermediary doctrine, which places the manufacturer’s duty to warn primarily on prescribers. See Carlin v. Superior Court (1996) 13 Cal.4th 1104. Strict-liability design-defect claims for prescription drugs are generally unavailable under Brown.
Key Evidence in SJS/TEN Drug Cases
- Medical records confirming SJS/TEN diagnosis (e.g., dermatology/burn unit notes, pathology/biopsy reports).
- A precise medication timeline (start/stop dates, dose changes, recent new prescriptions or OTC drugs).
- Pharmacy dispensing history, medication guides, and package inserts actually provided.
- Adverse event submissions and safety signals (e.g., FDA FAERS).
- Expert opinions on medical causation, labeling adequacy, and regulatory standards.
Causation in SJS/TEN
Proving causation typically requires qualified medical experts to address temporal association, differential diagnosis (ruling out other causes such as infections), and accepted causality criteria. For label-based claims, experts review the content and timing of warnings against contemporaneous medical literature and post-market safety data.
Damages Families May Recover
Available damages depend on the claim and the relationship to the decedent:
- Wrongful death damages may include loss of financial support, household services, and companionship. See § 377.61.
- Survival actions may recover economic losses the decedent sustained before death and, if within § 377.34(b)‘s effective window, certain non-economic damages.
- Punitive damages are generally not available in wrongful death but may be sought in a survival action if the evidence meets California’s clear-and-convincing standard. See Civ. Code § 3294.
Deadlines and Filing Considerations
California imposes strict, claim-specific deadlines. Many wrongful death actions have a two-year limitation period. See Code Civ. Proc. § 335.1. Certain claims—such as those involving alleged professional negligence by healthcare providers—have specialized rules and shorter outside limits. See § 340.5. Claims against public entities generally require a government claim within six months. See Gov. Code § 911.2. Because missing a deadline can bar recovery, consult counsel promptly to evaluate applicable timelines and notice requirements.
Practical Tips
- Document medication start and stop dates the same day you learn of a suspected reaction.
- Ask providers to note suspected drug causality in the chart and discharge summary.
- Request and save pharmacy printouts, medication guides, and any patient counseling notes.
- Keep all original packaging to preserve lot numbers.
What to Do If You Suspect an SJS/TEN Drug Reaction
- Seek immediate medical care and inform providers about all recent medications (prescription and OTC).
- Preserve pill bottles, blister packs, receipts, and any medication guides or leaflets you received.
- Request complete hospital and clinic records, including dermatology and pathology reports.
- Do not dispose of remaining medication until advised.
- Consult a lawyer experienced in pharmaceutical wrongful death litigation to assess liability, preemption, and expert needs.
How Our Firm Can Help
We investigate potential drug-related SJS/TEN deaths, retain medical and regulatory experts, preserve evidence, and pursue viable claims against manufacturers and distributors. We handle causation analysis, damages development, negotiations, and litigation while you focus on your family.
Ready to talk? Contact our California team.
Frequently Asked Questions
Who can file a wrongful death claim in California?
Eligible heirs typically include a surviving spouse or domestic partner, children, and others who were financially dependent, as defined by Code Civ. Proc. § 377.60.
How long do I have to file?
Many wrongful death claims must be filed within two years, but some claims have shorter or different rules. Speak with a lawyer promptly to confirm your deadlines.
Do warnings to doctors affect my claim?
Yes. Under the learned-intermediary doctrine, manufacturers generally owe their primary warnings to prescribers. Label adequacy and timing are often central issues.
Are claims against generic drug makers different?
They can be. Certain failure-to-warn claims against generics may be preempted by federal law, which can limit available theories.
What compensation is available?
Heirs may seek wrongful death damages for financial support and companionship. The estate may seek survival damages for losses the decedent sustained before death, and in some cases punitive damages via a survival action.
What should I bring to a consultation?
Medication containers, pharmacy records, hospital records, discharge summaries, and a timeline of drug exposure and symptoms.
Is there a cost to speak with your firm?
We offer free consultations, and many cases are handled on a contingency fee. Contact us to learn more.
Sources
- MedlinePlus: Stevens-Johnson Syndrome
- FDA: FAERS adverse event reporting
- Cal. Code Civ. Proc. § 377.60 (Wrongful death)
- Cal. Code Civ. Proc. § 377.61 (Damages)
- Cal. Code Civ. Proc. § 377.30 (Survival actions)
- Cal. Code Civ. Proc. § 377.34 (Survival damages)
- Cal. Code Civ. Proc. § 335.1 (Two-year limitation)
- Cal. Code Civ. Proc. § 340.5 (Medical negligence)
- Gov. Code § 911.2 (Government claims—6 months)
- Civ. Code § 3294 (Punitive damages)
- Brown v. Superior Court, 44 Cal.3d 1049 (1988)
- Carlin v. Superior Court, 13 Cal.4th 1104 (1996)
- Wyeth v. Levine, 555 U.S. 555 (2009)
- PLIVA, Inc. v. Mensing, 564 U.S. 604 (2011)
- Mutual Pharmaceutical Co. v. Bartlett, 570 U.S. 472 (2013)
- Merck Sharp & Dohme Corp. v. Albrecht, 587 U.S. ___ (2019)
Take the next step: Speak with a California attorney about your potential claim. Contact us today.